Skip to Content
Stock Strategist Industry Reports

Moderna Dominates COVID-19 Vaccine Manufacturers, at Least for Now

The global COVID-19 vaccine market is currently dominated by mRNA firms, but competitors are gaining strength.

Mentioned: , , , , , , , , ,

The development of the COVID-19 vaccine market will depend on several tough-to-predict outcomes, like the duration of vaccine protection, how variants evolve, and how competitors progress.

Despite the early lead that Moderna (MRNA) and BioNTech (BNTX) hold, and their clear dominance in the pandemic market for COVID-19 vaccine sales, we're not yet convinced that COVID-19 will require widespread annual booster shots, and if so, whether these companies will remain dominant in the long run.

Karen Andersen does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.